COVID-19 vaccine Sinopharm gains WHO emergency approval

By Christine Fabro

The World Health Organization (WHO) granted emergency use for the Sinopharm COVID-19 vaccine yesterday (May 7) to be rolled out globally – the first Chinese-made vaccine to gain WHO approval.

According to Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products, this additional listing has the potential to “rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk.”

The vaccine has an efficacy rate of 79% for symptomatic and hospitalized cases, and is recommended for adults 18 years and older, administered in a two-dose schedule.

The Sinopharm COVID-19 vaccine is also the first vaccine that will carry a vaccine vial monitor, which indicates whether the vaccine can be safely used and its easy storage requirements makes it highly suitable for low-resource settings.

WHO previously listed Pfizer/BioNTech, AstraZeneca/Oxford, Serum Institute of India, Janssen, and Moderna vaccines for emergency use. –WHO/CF-RIR

Popular

97% of Filipinos aware of VP Sara impeachment complaints—OCTA survey

By Dean Aubrey Caratiquet Majority of Filipinos across socio-economic classes and across the archipelago are aware of the impeachment complaints filed against Vice President Sara...

PBBM conducts aerial inspection of flood-hit Pampanga

By Ruth Abbey Gita-Carlos | Philippine News Agency President Ferdinand R. Marcos Jr. on Saturday conducted an aerial inspection of flood-stricken areas in Pampanga province. He...

DBM releases P1.625B to boost DSWD, DPWH calamity response efforts 

By Brian Campued The Department of Budget and Management (DBM) has released a total of P1.625 billion to replenish the Quick Response Funds (QRFs) of...

Palace defers to Congress, judiciary on impeachment process

By Ruth Abbey Gita-Carlos and Benjamin Pulta | Philippine News Agency Malacañang on Friday said it would allow Congress and the judiciary to exercise their...